210 related articles for article (PubMed ID: 34933890)
1. Effects of Tracer Uptake Time in Non-Small Cell Lung Cancer
Kolinger GD; García DV; Kramer GM; Frings V; Zwezerijnen GJC; Smit EF; de Langen AJ; Buvat I; Boellaard R
J Nucl Med; 2022 Jun; 63(6):919-924. PubMed ID: 34933890
[TBL] [Abstract][Full Text] [Related]
2. Repeatability of
Pfaehler E; Beukinga RJ; de Jong JR; Slart RHJA; Slump CH; Dierckx RAJO; Boellaard R
Med Phys; 2019 Feb; 46(2):665-678. PubMed ID: 30506687
[TBL] [Abstract][Full Text] [Related]
3. Repeatability of Radiomic Features in Non-Small-Cell Lung Cancer [(18)F]FDG-PET/CT Studies: Impact of Reconstruction and Delineation.
van Velden FH; Kramer GM; Frings V; Nissen IA; Mulder ER; de Langen AJ; Hoekstra OS; Smit EF; Boellaard R
Mol Imaging Biol; 2016 Oct; 18(5):788-95. PubMed ID: 26920355
[TBL] [Abstract][Full Text] [Related]
4. Repeatability of
Crandall JP; Fraum TJ; Lee M; Jiang L; Grigsby P; Wahl RL
J Nucl Med; 2021 May; 62(5):707-715. PubMed ID: 33008931
[TBL] [Abstract][Full Text] [Related]
5. Experimental Multicenter and Multivendor Evaluation of the Performance of PET Radiomic Features Using 3-Dimensionally Printed Phantom Inserts.
Pfaehler E; van Sluis J; Merema BBJ; van Ooijen P; Berendsen RCM; van Velden FHP; Boellaard R
J Nucl Med; 2020 Mar; 61(3):469-476. PubMed ID: 31420497
[TBL] [Abstract][Full Text] [Related]
6. Robustness of Radiomic Features in [
Lu L; Lv W; Jiang J; Ma J; Feng Q; Rahmim A; Chen W
Mol Imaging Biol; 2016 Dec; 18(6):935-945. PubMed ID: 27324369
[TBL] [Abstract][Full Text] [Related]
7. Robustness of [
Palomino-Fernández D; Seiffert AP; Gómez-Grande A; Jiménez López-Guarch C; Moreno G; Bueno H; Gómez EJ; Sánchez-González P
Comput Methods Programs Biomed; 2024 Feb; 244():107981. PubMed ID: 38154326
[TBL] [Abstract][Full Text] [Related]
8. Interchangeability of radiomic features between [18F]-FDG PET/CT and [18F]-FDG PET/MR.
Vuong D; Tanadini-Lang S; Huellner MW; Veit-Haibach P; Unkelbach J; Andratschke N; Kraft J; Guckenberger M; Bogowicz M
Med Phys; 2019 Apr; 46(4):1677-1685. PubMed ID: 30714158
[TBL] [Abstract][Full Text] [Related]
9. Repeatability of Quantitative Whole-Body 18F-FDG PET/CT Uptake Measures as Function of Uptake Interval and Lesion Selection in Non-Small Cell Lung Cancer Patients.
Kramer GM; Frings V; Hoetjes N; Hoekstra OS; Smit EF; de Langen AJ; Boellaard R
J Nucl Med; 2016 Sep; 57(9):1343-9. PubMed ID: 27103020
[TBL] [Abstract][Full Text] [Related]
10. Repeatability of [
Kolinger GD; Vállez García D; Kramer GM; Frings V; Smit EF; de Langen AJ; Dierckx RAJO; Hoekstra OS; Boellaard R
EJNMMI Res; 2019 Feb; 9(1):14. PubMed ID: 30734113
[TBL] [Abstract][Full Text] [Related]
11. Variability and Repeatability of Quantitative Uptake Metrics in
Zhuang M; García DV; Kramer GM; Frings V; Smit EF; Dierckx R; Hoekstra OS; Boellaard R
J Nucl Med; 2019 May; 60(5):600-607. PubMed ID: 30389824
[TBL] [Abstract][Full Text] [Related]
12. Repeatability of Radiomic Features of Brown Adipose Tissue.
Nazeri A; Crandall JP; Fraum TJ; Wahl RL
J Nucl Med; 2021 May; 62(5):700-706. PubMed ID: 33037091
[TBL] [Abstract][Full Text] [Related]
13. Reproducibility of F18-FDG PET radiomic features for different cervical tumor segmentation methods, gray-level discretization, and reconstruction algorithms.
Altazi BA; Zhang GG; Fernandez DC; Montejo ME; Hunt D; Werner J; Biagioli MC; Moros EG
J Appl Clin Med Phys; 2017 Nov; 18(6):32-48. PubMed ID: 28891217
[TBL] [Abstract][Full Text] [Related]
14.
Lasnon C; Majdoub M; Lavigne B; Do P; Madelaine J; Visvikis D; Hatt M; Aide N
Eur J Nucl Med Mol Imaging; 2016 Dec; 43(13):2324-2335. PubMed ID: 27325312
[TBL] [Abstract][Full Text] [Related]
15. Impact of acquisition count statistics reduction and SUV discretization on PET radiomic features in pediatric 18F-FDG-PET/MRI examinations.
Branchini M; Zorz A; Zucchetta P; Bettinelli A; De Monte F; Cecchin D; Paiusco M
Phys Med; 2019 Mar; 59():117-126. PubMed ID: 30928060
[TBL] [Abstract][Full Text] [Related]
16. Repeatability of 18F-FDG PET/CT in Advanced Non-Small Cell Lung Cancer: Prospective Assessment in 2 Multicenter Trials.
Weber WA; Gatsonis CA; Mozley PD; Hanna LG; Shields AF; Aberle DR; Govindan R; Torigian DA; Karp JS; Yu JQ; Subramaniam RM; Halvorsen RA; Siegel BA; ;
J Nucl Med; 2015 Aug; 56(8):1137-43. PubMed ID: 25908829
[TBL] [Abstract][Full Text] [Related]
17. Optimized Feature Extraction for Radiomics Analysis of
Papp L; Rausch I; Grahovac M; Hacker M; Beyer T
J Nucl Med; 2019 Jun; 60(6):864-872. PubMed ID: 30389820
[TBL] [Abstract][Full Text] [Related]
18. Why harmonization is needed when using FDG PET/CT as a prognosticator: demonstration with EARL-compliant SUV as an independent prognostic factor in lung cancer.
Houdu B; Lasnon C; Licaj I; Thomas G; Do P; Guizard AV; Desmonts C; Aide N
Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):421-428. PubMed ID: 30218317
[TBL] [Abstract][Full Text] [Related]
19. Quantitative and clinical implications of the EARL2 versus EARL1 [
Cox MC; Jurcka T; Arens AIJ; van Rijk MC; Kaanders JHAM; van den Bosch S
EJNMMI Res; 2023 Oct; 13(1):91. PubMed ID: 37878160
[TBL] [Abstract][Full Text] [Related]
20. Synergistic impact of motion and acquisition/reconstruction parameters on
Hosseini SA; Shiri I; Hajianfar G; Bahadorzadeh B; Ghafarian P; Zaidi H; Ay MR
Med Phys; 2022 Jun; 49(6):3783-3796. PubMed ID: 35338722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
